124 related articles for article (PubMed ID: 25445539)
1. Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome.
Lehotzky A; Oláh J; Szunyogh S; Szabó A; Berki T; Ovádi J
Biochim Biophys Acta; 2015 Jan; 1852(1):83-91. PubMed ID: 25445539
[TBL] [Abstract][Full Text] [Related]
2. Dual life of TPPP/p25 evolved in physiological and pathological conditions.
Oláh J; Ovádi J
Biochem Soc Trans; 2014 Dec; 42(6):1762-7. PubMed ID: 25399603
[TBL] [Abstract][Full Text] [Related]
3. Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25.
Tőkési N; Oláh J; Hlavanda E; Szunyogh S; Szabó A; Babos F; Magyar A; Lehotzky A; Vass E; Ovádi J
Biochim Biophys Acta; 2014 Apr; 1842(4):547-57. PubMed ID: 24463170
[TBL] [Abstract][Full Text] [Related]
4. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6.
Tokési N; Lehotzky A; Horváth I; Szabó B; Oláh J; Lau P; Ovádi J
J Biol Chem; 2010 Jun; 285(23):17896-906. PubMed ID: 20308065
[TBL] [Abstract][Full Text] [Related]
5. Localization of the zinc binding tubulin polymerization promoting protein in the mice and human eye.
Tripon RG; Oláh J; Nasir T; Csincsik L; Li CL; Szunyogh S; Gong H; Flinn JM; Ovádi J; Lengyel I
J Trace Elem Med Biol; 2018 Sep; 49():222-230. PubMed ID: 29317136
[TBL] [Abstract][Full Text] [Related]
6. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
Oláh J; Vincze O; Virók D; Simon D; Bozsó Z; Tõkési N; Horváth I; Hlavanda E; Kovács J; Magyar A; Szũcs M; Orosz F; Penke B; Ovádi J
J Biol Chem; 2011 Sep; 286(39):34088-100. PubMed ID: 21832049
[TBL] [Abstract][Full Text] [Related]
7. Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins.
Szénási T; Oláh J; Szabó A; Szunyogh S; Láng A; Perczel A; Lehotzky A; Uversky VN; Ovádi J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):310-323. PubMed ID: 27671864
[TBL] [Abstract][Full Text] [Related]
8. Microtubule assembly-derived by dimerization of TPPP/p25. Evaluation of thermodynamic parameters for multiple equilibrium system from ITC data.
Oláh J; Zotter Á; Hlavanda E; Szunyogh S; Orosz F; Szigeti K; Fidy J; Ovádi J
Biochim Biophys Acta; 2012 Jul; 1820(7):785-94. PubMed ID: 22484033
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for microtubule-independent dimerization of TPPP/p25.
Oláh J; Szénási T; Szunyogh S; Szabó A; Lehotzky A; Ovádi J
Sci Rep; 2017 Jan; 7():40594. PubMed ID: 28074911
[TBL] [Abstract][Full Text] [Related]
10. Zn²+-induced rearrangement of the disordered TPPP/p25 affects its microtubule assembly and GTPase activity.
Zotter Á; Oláh J; Hlavanda E; Bodor A; Perczel A; Szigeti K; Fidy J; Ovádi J
Biochemistry; 2011 Nov; 50(44):9568-78. PubMed ID: 21995432
[TBL] [Abstract][Full Text] [Related]
11. Targeting the interface of the pathological complex of α-synuclein and TPPP/p25.
Szunyogh S; Oláh J; Szénási T; Szabó A; Ovádi J
Biochim Biophys Acta; 2015 Dec; 1852(12):2653-61. PubMed ID: 26407520
[TBL] [Abstract][Full Text] [Related]
12. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
[TBL] [Abstract][Full Text] [Related]
13. Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential.
Oláh J; Bertrand P; Ovádi J
Expert Rev Proteomics; 2017 Apr; 14(4):301-309. PubMed ID: 28271739
[TBL] [Abstract][Full Text] [Related]
14. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis.
Höftberger R; Fink S; Aboul-Enein F; Botond G; Olah J; Berki T; Ovadi J; Lassmann H; Budka H; Kovacs GG
Glia; 2010 Nov; 58(15):1847-57. PubMed ID: 20737479
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological targeting of α-synuclein and TPPP/p25 in Parkinson's disease: challenges and opportunities in a Nutshell.
Oláh J; Ovádi J
FEBS Lett; 2019 Jul; 593(13):1641-1653. PubMed ID: 31148150
[TBL] [Abstract][Full Text] [Related]
16. Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their Proteolytic Degradation in Human Cell Models.
Lehotzky A; Oláh J; Fekete JT; Szénási T; Szabó E; Győrffy B; Várady G; Ovádi J
Front Mol Biosci; 2021; 8():666026. PubMed ID: 34084775
[TBL] [Abstract][Full Text] [Related]
17. Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein.
Oláh J; Lehotzky A; Szénási T; Ovádi J
Cells; 2021 Oct; 10(11):. PubMed ID: 34831132
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-Associated Proteins with Regulatory Functions by Day and Pathological Potency at Night.
Oláh J; Lehotzky A; Szunyogh S; Szénási T; Orosz F; Ovádi J
Cells; 2020 Feb; 9(2):. PubMed ID: 32033023
[TBL] [Abstract][Full Text] [Related]
19. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies.
Kovács GG; László L; Kovács J; Jensen PH; Lindersson E; Botond G; Molnár T; Perczel A; Hudecz F; Mezo G; Erdei A; Tirián L; Lehotzky A; Gelpi E; Budka H; Ovádi J
Neurobiol Dis; 2004 Nov; 17(2):155-62. PubMed ID: 15474353
[TBL] [Abstract][Full Text] [Related]
20. TPPP/p25: from unfolded protein to misfolding disease: prediction and experiments.
Orosz F; Kovács GG; Lehotzky A; Oláh J; Vincze O; Ovádi J
Biol Cell; 2004 Dec; 96(9):701-11. PubMed ID: 15567525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
